The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Brain Infarction and the Clinical Expression of Alzheimer Disease<subtitle>The Nun Study</subtitle>
Abstract
Objective. —To determine the relationship of brain infarction to the clinical expression of Alzheimer disease (AD). Design. —Cognitive function and the prevalence of dementia were determined for participants in the Nun Study who later died. At autopsy, lacunar and larger brain infarcts were identified, and senile plaques and neurofibrillary tangles in the neocortex were quantitated. Participants with abundant senile plaques and some neurofibrillary tangles in the neocortex were classified as having met the neuropathologic criteria for AD. Setting. —Convents in the Midwestern, Eastern, and Southern United States. Participants. —A total of 102 college-educated women aged 76 to 100 years. Main Outcome Measures. —Cognitive function assessed by standard tests and dementia and AD assessed by clinical and neuropathologic criteria. Results. —Among 61 participants who met the neuropathologic criteria for AD, those with brain infarcts had poorer cognitive function and a higher prevalence of dementia than those without infarcts. Participants with lacunar infarcts in the basal ganglia, thalamus, or deep white matter had an especially high prevalence of dementia, compared with those without infarcts (the odds ratio [OR] for dementia was 20.7,95% confidence interval [95% CI], 1.5-288.0). Fewer neuropathologic lesions of AD appeared to result in dementia in those with lacunar infarcts in the basal ganglia, thalamus, or deep white matter than in those without infarcts. In contrast, among 41 participants who did not meet the neuropathologic criteria for AD, brain infarcts were only weakly associated with poor cognitive function and dementia. Among all 102 participants, atherosclerosis of the circle of Willis was strongly associated with lacunar and large brain infarcts. Conclusion. —These findings suggest that cerebrovascular disease may play an important role in determining the presence and severity of the clinical symptoms of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Population-autopsy series verified the high frequency and pathogenetic importance of combined Alzheimer disease and vascular disease in the expression of dementia as mentioned previously.”
In the citing paper
“Furthermore, vascular lesions can lower the threshold for the clinical manifestation of Alzheimer disease.”
In the citing paper
“Several studies have found that in patients with Alzheimer disease and cerebrovascular disease, less Alzheimer disease pathology is needed to express the dementia syndrome.”
In the citing paper
“typically are accompanied by Alzheimer disease and other pathologies.”
In the citing paper
“Infarcts frequently coexist with Alzheimer disease pathology in the brains of older people.”
In the citing paper
“One study showed that only people with Alzheimer disease pathology with subcortical infarcts had dementia, raising the possibility of an interaction (a multiplicative effect) between the 2 pathologies.”
In the citing paper
“It is now accepted that many of the traditional risk factors for stroke are also risk markers for Alzheimer disease and VCI.16,31,340,484–491”
In the citing paper
“Lacunes are frequently seen on imaging in elderly patients with no symptoms”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“are associated with an increased risk of stroke, gait impairment, and dementia.”
From Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration (2013) · cites this paper as [25]
In the citing paper
“Cerebrovascular effects of APOE4 are associated with AD, stroke, and brain hemorrhage (314, 506, 549, 614, 693).”
From Blood-Brain Barrier: From Physiology to Disease and Back (2019) · cites this paper as [549]
In the citing paper
“Classical anatomic locations for strategic infarcts include the thalamus, angular gyrus, and basal ganglia, including the caudate nucleus and globus pallidus. 52-57”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“A single small infarct may cause severe cognitive deficits when located in a strategic brain region.”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“However, vascular brain lesions lower the threshold of AD pathology required to induce dementia. 56,100-102”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“Earlier studies have suggested a multiplicative effect between vascular and AD-type pathology on cognitive decline, 56 whereas recent studies indicate that the effects are additive. 49,100,105”
From Vascular Cognitive Impairment (2017) · cites this paper as [56]
In the citing paper
“many older individuals with dementia suffer from a combination of vascular and Alzheimer-type pathology with an additive effect on cognition,19”
From Diagnostic Criteria for Vascular Cognitive Disorders: A VASCOG Statement (2014) · cites this paper as [19]
In the citing paper
“On the other hand, in older individuals with moderate AD pathology subcortical vascular lesions are a major determinant of the expression of the dementia (Esiri et al., 1999; Schneider et al., 2007b; Snowdon et al., 1997).”
From The Pathobiology of Vascular Dementia (2013) · cites this paper as Snowdon et al., 1997
In the citing paper
“it seems reasonable to postulate that insulin resistance and T2D could increase AD risk through cerebrovascular disease, a factor increasingly accepted to be important in AD manifestation [5, 19-21].”
From Metformin in Amnestic Mild Cognitive Impairment: Results of a Pilot Randomized Placebo Controlled Clinical Trial (2016) · cites this paper as [5]
Citations
Cites
The publisher hasn’t deposited this paper’s reference list.
Cited by
Sorted by citations
Items 201–300 of 1,644
Dementia, stroke, and vascular risk factors; a review
Sahathevan, R., Brodtmann, A., & Donnan, G. A. (2012) · International Journal of Stroke · doi:10.1111/j.1747-4949.2011.00731.x · Cited by 230
Cerebrovascular Disease and Mechanisms of Cognitive Impairment
Kalaria, R. N. (2012) · Stroke · doi:10.1161/strokeaha.112.655803 · Cited by 234
Wyss‐Coray, T., Lin, C., Sanan, D. A., Mucke, L., & Masliah, E. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64713-x · Cited by 225
The enigma of vascular cognitive disorder and vascular dementia
Jellinger, K. A. (2007) · Acta Neuropathologica · doi:10.1007/s00401-006-0185-2 · Cited by 166
Mixed Dementia—the Most Common Cause of Dementia
KORCZYN, A. D. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04807.x · Cited by 219
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Van Acker, Z. P., Bretou, M., & Annaert, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0323-7 · Cited by 222
Rabin, J. S., Schultz, A. P., Hedden, T., Viswanathan, A., Marshall, G. A., Kilpatrick, E., Klein, H., Buckley, R. F., Yang, H.-S., Properzi, M., et al. (2018) · JAMA Neurology · doi:10.1001/jamaneurol.2018.1123 · Cited by 221
Consensus statement for diagnosis of subcortical small vessel disease
Rosenberg, G. A., Wallin, A., Wardlaw, J. M., Markus, H. S., Montaner, J., WOLFSON, L. I., Iadecola, C., Zloković, B. V., Joutel, A., Dichgans, M., et al. (2015) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2015.172 · Cited by 228
Is Alzheimer’s disease a systemic disease?
Morris, J. K., Honea, R. A., Vidoni, E. D., Swerdlow, R. H., & Burns, J. M. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.04.012 · Cited by 219
Effect of infarcts on dementia in the Baltimore longitudinal study of aging
Troncoso, J. C., Zonderman, A. B., Resnick, S. M., Crain, B., Pletnikova, O., & O'Brien, R. J. (2008) · Annals of Neurology · doi:10.1002/ana.21413 · Cited by 219
Vascular Dementia: Distinguishing Characteristics, Treatment, and Prevention
Román, G. C. (2003) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.5155.x · Cited by 222
Morris, M. C., Scherr, P. A., Hebert, L. E., Glynn, R. J., Bennett, D. A., & Evans, D. A. (2001) · Archives of Neurology · doi:10.1001/archneur.58.10.1640 · Cited by 217
Combined neuropathological pathways account for age‐related risk of dementia
Power, M. C., Mormino, E. C., Soldan, A., James, B. D., Yu, L., Armstrong, N. M., Bangen, K. J., Delano‐Wood, L., Lamar, M., Lim, Y. Y., et al. (2018) · Annals of Neurology · doi:10.1002/ana.25246 · Cited by 215
Anderson, C., Teo, K., Gao, P., Arima, H., Dans, A., Unger, T., Commerford, P., Dyal, L., Schumacher, H., Pogue, J., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70250-7 · Cited by 216
The Relationship between Obstructive Sleep Apnea and Alzheimer’s Disease
Andrade, A. G., Bubu, O. M., Varga, A. W., & Osorio, R. S. (2018) · Journal of Alzheimer's Disease · doi:10.3233/jad-179936 · Cited by 216
Morris, G. P., Clark, I. A., & Vissel, B. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1918-8 · Cited by 212
Neuropsychological Contributions to the Early Identification of Alzheimer’s Disease
Bondi, M. W., Jak, A. J., Delano-Wood, L., Jacobson, M. W., Delis, D. C., & Salmon, D. P. (2008) · Neuropsychology Review · doi:10.1007/s11065-008-9054-1 · Cited by 216
Suo, C., Singh, M. F., Gates, N., Wen, W., Sachdev, P., Brodaty, H., Saigal, N., Wilson, G. C., Meiklejohn, J., Singh, N., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2016.19 · Cited by 212
Diet, cognition, and alzheimer’s disease: food for thought
Otaegui-Arrazola, A., Amiano, P., Elbusto, A., Urdaneta, E., & Martínez-Lage, P. (2014) · European Journal of Nutrition · doi:10.1007/s00394-013-0561-3 · Cited by 214
Kapasi, A., & Schneider, J. A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.12.023 · Cited by 221
Power, M. C., Weuve, J., Gagne, J. J., McQueen, M. B., Viswanathan, A., & Blacker, D. (2011) · Epidemiology · doi:10.1097/ede.0b013e31822708b5 · Cited by 213
Vascular determinants of cholinergic deficits in Alzheimer disease and vascular dementia.
Román, G. C., & Kalaria, R. N. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.10.004 · Cited by 213
Hypertension, Brain Damage and Cognitive Decline
Gąsecki, D., Kwarciany, M., Nyka, W. M., & Narkiewicz, K. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0398-4 · Cited by 228
Chow, N., Bell, R. D., Deane, R., Streb, J. W., Chen, J., Brooks, A., Van Nostrand, W., Miano, J. M., & Zlokovic, B. V. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608251104 · Cited by 209
Role of Vascular Risk Factors and Vascular Dysfunction in Alzheimer's Disease
Dickstein, D. L., Walsh, J., Brautigam, H., Stockton, S. D., Gandy, S., & Hof, P. R. (2010) · Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20155 · Cited by 155
Lin, A., Zheng, W., Halloran, J. J., Burbank, R. R., Hussong, S. A., Hart, M. J., Javors, M. A., Shih, Y. I., Muir, E. R., Fonseca, R. S., et al. (2013) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2013.82 · Cited by 209
Alzheimer’s Disease And Inflammation: A Review Of Cellular And Therapeutic Mechanisms
Halliday, G. M., Robinson, S. R., Shepherd, C. E., & Kril, J. J. (2000) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2000.03200.x · Cited by 209
Converging Pathogenic Mechanisms in Vascular and Neurodegenerative Dementia
Iadecola, C., & Gorelick, P. B. (2003) · Stroke · doi:10.1161/01.str.0000054050.51530.76 · Cited by 208
Nagai, M., Hoshide, S., & Kario, K. (2009) · American Journal of Hypertension · doi:10.1038/ajh.2009.212 · Cited by 216
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease
Heyman, A., Fillenbaum, G. G., Welsh-Bohmer, K. A., Gearing, M., Mirra, S. S., Mohs, R. C., Peterson, B. L., & Pieper, C. F. (1998) · Neurology · doi:10.1212/wnl.51.1.159 · Cited by 206
A summary risk score for the prediction of Alzheimer disease in elderly persons
Reitz, C., Tang, M.-X., Schupf, N., Manly, J. J., Mayeux, R., & Luchsinger, J. A. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.136 · Cited by 199
Association Between Oral Health and Cognitive Status: A Systematic Review
Wu, B., Fillenbaum, G. G., Plassman, B. L., & Guo, L. (2016) · Journal of the American Geriatrics Society · doi:10.1111/jgs.14036 · Cited by 205
Cortical Microinfarcts and Demyelination Significantly Affect Cognition in Brain Aging
Kövari, E., Gold, G., Herrmann, F. R., Canuto, A., Hof, P. R., Michel, J.-P., Bouras, C., & Giannakopoulos, P. (2004) · Stroke · doi:10.1161/01.str.0000110791.51378.4e · Cited by 202
Reisberg, ., Franssen, E., Souren, L. E. M., Auer, S., Akram, I., & Kenowsky, S. (2002) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750201700411 · Cited by 205
Atrial Fibrillation and Cognitive Function
Diener, H., Hart, R. G., Koudstaal, P. J., Lane, D. A., & Lip, G. Y. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.10.077 · Cited by 209
Apolipoprotein E and the CNS Response to Injury
Laskowitz, D. T., Horsburgh, K., & Roses, A. D. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199805000-00001 · Cited by 201
Transcriptional Regulation of β-Secretase by p25/cdk5 Leads to Enhanced Amyloidogenic Processing
Wen, Y., Yu, W. H., Maloney, B., Bailey, J. A., Ma, J., Marié, I., Maurin, T., Wang, L., Figueroa, H. Y., Herman, M., et al. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.024 · Cited by 201
Emerging roles of pathogens in Alzheimer disease
Miklossy, J. (2011) · Expert Reviews in Molecular Medicine · doi:10.1017/s1462399411002006 · Cited by 206
Getting to the Heart of Alzheimer Disease
Tublin, J. M., Adelstein, J. M., del Monte, F., Combs, C. K., & Wold, L. E. (2019) · Circulation Research · doi:10.1161/circresaha.118.313563 · Cited by 188
NMDA Receptor Activation Inhibits α-Secretase and Promotes Neuronal Amyloid-β Production
Lesné, S., Ali, C., Gabriel, C., Croci, N., MacKenzie, E. T., Glabe, C. G., Plotkine, M., Marchand‐Leroux, C., Vivien, D., & Buisson, A. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.0849-05.2005 · Cited by 211
Gold, G., Kövari, E., Herrmann, F. R., Canuto, A., Hof, P. R., Michel, J., Bouras, C., & Giannakopoulos, P. (2005) · Stroke · doi:10.1161/01.str.0000166052.89772.b5 · Cited by 200
AbuRahma, A. F., Avgerinos, E. D., Chang, R. W., Darling, R. C., Duncan, A. A., Forbes, T. L., Malas, M. B., Perler, B. A., Powell, R. J., Rockman, C. R., et al. (2021) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2021.04.074 · Cited by 202
Statins for the prevention of dementia
McGuinness, B., Craig, D., Bullock, R., & Passmore, P. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003160.pub2 · Cited by 193
Coburn, K. L., Lauterbach, E. C., Boutros, N. N., BLACK, K. J., Arciniegas, D. B., & Coffey, C. E. (2006) · Journal of Neuropsychiatry · doi:10.1176/jnp.2006.18.4.460 · Cited by 192
Galantamine treatment of vascular dementia: A randomized trial
Auchus, A. P., Brashear, H. R., Salloway, S., Korczyn, A. D., De Deyn, P. P., & Gassmann-Mayer, C. (2007) · Neurology · doi:10.1212/01.wnl.0000266625.31615.f6 · Cited by 189
Mixed neuropathologies and estimated rates of clinical progression in a large autopsy sample
Brenowitz, W. D., Hubbard, R. A., Keene, C. D., Hawes, S. E., Longstreth, W. T., Woltjer, R. L., & Kukull, W. A. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.09.015 · Cited by 188
Mortimer, J. A., Borenstein, A. R., Gosche, K. M., & Snowdon, D. A. (2005) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988705281869 · Cited by 194
Self-citationImpact of White Matter Changes on Clinical Manifestation of Alzheimer’s Disease
Hirono, N., Kitagaki, H., Kazui, H., Hashimoto, M., & Mori, E. (2000) · Stroke · doi:10.1161/01.str.31.9.2182 · Cited by 186
Extracellular matrix inflammation in vascular cognitive impairment and dementia
Rosenberg, G. A. (2017) · Clinical Science · doi:10.1042/cs20160604 · Cited by 214
Pulse Pressure and Risk of Alzheimer Disease in Persons Aged 75 Years and Older
Qiu, C., Winblad, B. G., Viitanen, M. H., & Fratiglioni, L. (2003) · Stroke · doi:10.1161/01.str.0000060127.96986.f4 · Cited by 184
Donepezil for vascular cognitive impairment
Malouf, R. S., & Birks, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004395.pub2 · Cited by 182
Reich, E. E., Markesbery, W. R., Roberts, L. J., Swift, L. L., Morrow, J. D., & Montine, T. J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63968-5 · Cited by 183
Alzheimer’s Disease: The Link Between Amyloid-β and Neurovascular Dysfunction
Solis, E., Hascup, K. N., & Hascup, E. R. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200473 · Cited by 192
High Levels of Circulating Aβ42 Are Sequestered by Plasma Proteins in Alzheimer's Disease
Kuo, Y., Emmerling, M. R., Lampert, H. C., Hempelman, S. R., Kokjohn, T. A., Woods, A. S., Cotter, R. J., & Roher, A. E. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0552 · Cited by 183
Scuteri, A., Tesauro, M., Appolloni, S., Preziosi, F., Brancati, A. M., & Volpe, M. (2007) · Journal of Hypertension · doi:10.1097/hjh.0b013e3280895b55 · Cited by 181
Peters, N., Opherk, C., Danek, A., Ballard, C., Herzog, J., & Dichgans, M. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.11.2078 · Cited by 178
Dementia and cognitive impairment three months after stroke
MADUREIRA, S., Guerreiro, M., & Ferro, J. M. (2001) · European Journal of Neurology · doi:10.1046/j.1468-1331.2001.00332.x · Cited by 181
Wessels, A. M., Şimşek, S., Remijnse, P. L., Veltman, D. J., Biessels, G. J., Barkhof, F., Scheltens, P., Snoek, F. J., Heine, R. J., & Rombouts, S. A. R. B. (2006) · Diabetologia · doi:10.1007/s00125-006-0283-7 · Cited by 177
Blood pressure and the risk for dementia—A double edged sword
Kennelly, S. P., Lawlor, B. A., & Kenny, R. A. (2009) · Ageing Research Reviews · doi:10.1016/j.arr.2008.11.001 · Cited by 173
DeKosky, S. T., Fitzpatrick, A., Ives, D. G., Saxton, J., Williamson, J., Lopez, O. L., Burke, G., Fried, L., Kuller, L. H., Robbins, J., et al. (2006) · Contemporary Clinical Trials · doi:10.1016/j.cct.2006.02.007 · Cited by 176
Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?
Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174
Comorbidity and dementia: A nationwide survey in Taiwan
Chen, T., Yiao, S.-Y., Sun, Y., Lee, H.-J., Yang, S.-C., Chiu, M., Chen, T., Lin, K.-N., Tang, L.-Y., Lin, C., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0175475 · Cited by 177
Mattson, M. P., Zhu, H., Yu, J., & Kindy, M. S. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-04-01358.2000 · Cited by 172
Neuropathologic comorbidity and cognitive impairment in the Nun and Honolulu-Asia Aging Studies
White, L. R., Edland, S. D., Hemmy, L. S., Montine, K. S., Zarow, C., Sonnen, J. A., Uyehara‐Lock, J. H., Gelber, R. P., Ross, G. W., Petrovitch, H., et al. (2016) · Neurology · doi:10.1212/wnl.0000000000002480 · Cited by 174
Cardiovascular Disease and Alzheimer's Disease: The Heart–Brain Axis
Saeed, A., López, O. L., Cohen, A. D., & Reís, S. E. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030780 · Cited by 181
Adiposity and Alzheimer's disease
Luchsinger, J. A., & Gustafson, D. (2008) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32831c8c71 · Cited by 181
Debette, S., Bombois, S., Bruandet, A., Delbeuck, X., Lepoittevin, S., Delmaire, C., Leys, D., & Pasquier, F. (2007) · Stroke · doi:10.1161/strokeaha.107.488403 · Cited by 167
Gallaway, P. J., Miyake, H., Buchowski, M. S., Shimada, M., YOSHITAKE, Y., Kim, A., & Hongu, N. K. (2017) · Brain Sciences · doi:10.3390/brainsci7020022 · Cited by 177
Yang, S., Bae, D., Kang, H. J., Gwag, B. J., Gho, Y. S., & Chae, C. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00111-8 · Cited by 178
Gray Matter Atrophy in Patients With Ischemic Stroke With Cognitive Impairment
Stebbins, G. T., Nyenhuis, D. L., Wang, C., Cox, J. L., Freels, S. A., Bangen, K. J., deToledo‐Morrell, L., Sripathirathan, K., Moseley, M. E., Turner, D. A., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.507392 · Cited by 166
Kuo, Y.-M., Kokjohn, T. A., Watson, M. D., Woods, A. S., Cotter, R. J., Sue, L. I., Kalback, W. M., Emmerling, M. R., Beach, T. G., & Roher, A. E. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64947-4 · Cited by 167
Jefferson, A. L., Beiser, A. S., Himali, J. J., Seshadri, S., O’Donnell, C. J., Manning, W. J., Wolf, P. A., Au, R., & Benjamin, E. J. (2015) · Circulation · doi:10.1161/circulationaha.114.012438 · Cited by 169
Rundén‐Pran, E., Seglen, P. O., Haug, F. Š., Ottersen, O. P., Wieloch, T. W., Shamloo, M., & Laake, J. H. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-18-07296.1998 · Cited by 167
Gemmell, E., Bosomworth, H. J., Allan, L. M., Hall, R., Khundakar, A. A., Oakley, A. E., Deramecourt, V., Polvikoski, T. M., O'Brien, J. T., & Kalaria, R. N. (2011) · Stroke · doi:10.1161/strokeaha.111.636498 · Cited by 170
Obstructive Sleep Apnea and Longitudinal Alzheimer's Disease Biomarker Changes
Bubu, O. M., Pirraglia, E., Andrade, A. G., Sharma, R. A., Giménez, S., Umasabor‐Bubu, O. Q., Hogan, M. M., Shim, A., Mukhtar, F., Sharma, N. K., et al. (2018) · SLEEP · doi:10.1093/sleep/zsz048 · Cited by 176
. Identification of Alzheimer and vascular lesion thresholds for mixed dementia.
Gold, G., Giannakopoulos, P., Herrmann, F. R., Bouras, C., & Kovari, E. (2007) · Brain · doi:10.1093/brain/awm228 · Cited by 163
Transitions to mild cognitive impairments, dementia, and death: findings from the Nun Study
Tyas, S. L., Salazar, J. C., Snowdon, D. A., Desrosiers, M. F., Riley, K. P., Mendiondo, M. S., & Kryscio, R. J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm085 · Cited by 163
Self-citationHomocysteine, vitamin B 6 , and vascular disease in AD patients
Miller, J. W., Green, R., Mungas, D., Reed, B. R., & Jagust, W. (2002) · Neurology · doi:10.1212/wnl.58.10.1471 · Cited by 164
Clare, R., King, V. G., Wirenfeldt, M., & Vinters, H. V. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22392 · Cited by 163
The neuropsychological profile of vascular cognitive impairment not demented: A meta‐analysis
Vasquez, B. P., & Zakzanis, K. K. (2014) · Journal of Neuropsychology · doi:10.1111/jnp.12039 · Cited by 162
Kester, M. I., Goos, J. D. C., Teunissen, C. E., Benedictus, M. R., Bouwman, F. H., Wattjes, M. P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.754 · Cited by 161
Burns, J. M., Church, J. A., Johnson, D. K., Xiong, C., Marcus, D., Fotenos, A. F., Snyder, A. Z., Morris, J. C., & Buckner, R. L. (2005) · Archives of Neurology · doi:10.1001/archneur.62.12.1870 · Cited by 155
Koistinaho, M., Kettunen, M. I., Goldsteins, G., Keinänen, R., Salminen, A., Ort, M., Bures, J., Liu, D., Kauppinen, R. A., Higgins, L. S., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032670899 · Cited by 159
CSF biomarkers predict rate of cognitive decline in Alzheimer disease
Kester, M. I., van der Vlies, A. E., Blankenstein, M. A., Pijnenburg, Y. A. L., van Elk, E. J., Scheltens, P., & van der Flier, W. M. (2009) · Neurology · doi:10.1212/wnl.0b013e3181bd8271 · Cited by 159
Early-onset and delayed-onset poststroke dementia — revisiting the mechanisms
Mok, V., Lam, B. Y. K., Wong, A., Ko, H., Markus, H. S., & Wong, K. S. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.16 · Cited by 159
Corrada, M. M., Kawas, C. H., Hallfrisch, J. G., Muller, D. C., & Brookmeyer, R. (2005) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2005.06.001 · Cited by 160
Research evaluation and diagnosis of probable Alzheimer’s disease over the last two decades: I
López, O. L., Becker, J. T., Klunk, W. E., Saxton, J. A., Hamilton, R. L., Kaufer, D., Sweet, R. A., MELTZER, C. C., Wisniewski, S. R., Kamboh, M. I., et al. (2000) · Neurology · doi:10.1212/wnl.55.12.1854 · Cited by 157
Carlson, G. A., Borchelt, D. R., Dake, A., Turner, S., Danielson, V., Coffin, J. D., Eckman, C., Meiners, J., Nilsen, S. P., Younkin, S. G., et al. (1997) · Human Molecular Genetics · doi:10.1093/hmg/6.11.1951 · Cited by 158
Hypertension and cognitive dysfunction in elderly: blood pressure management for this global burden
Tadić, M., Cuspidi, C., & Hering, D. (2016) · BMC Cardiovascular Disorders · doi:10.1186/s12872-016-0386-0 · Cited by 170
Vascular burden and Alzheimer disease pathologic progression
Lo, R. Y., Jagust, W. J., Weiner, M., Aisen, P., Weiner, M., Aisen, P., Petersen, R., Jack, C. R., Jagust, W., Trojanowki, J. Q., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e31826c1b9d · Cited by 156
Kantarci, K., Weigand, S. D., Przybelski, S. A., Shiung, M. M., Whitwell, J. L., Negash, S., Knopman, D. S., Boeve, B. F., O’Brien, P. C., Petersen, R. C., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e864 · Cited by 160
APOE , vascular pathology, and the AD brain
Yip, A. G., McKee, A. C., Green, R. C., WELLS, J. S., Young, H., Cupples, L. A., & Farrer, L. A. (2005) · Neurology · doi:10.1212/01.wnl.0000168863.49053.4d · Cited by 155
Advancements in nanotherapeutics for Alzheimer’s disease: current perspectives
Harilal, S., Jose, J., Parambi, D. G. T., Kumar, R., Mathew, G. E., Uddin, M. S., Kim, H., & Mathew, B. (2019) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13132 · Cited by 158
Abnormal Regional Cerebral Blood Flow in Cognitively Normal Elderly Subjects With Hypertension
Dai, W., López, O. L., Carmichael, O. T., Becker, J. T., Kuller, L. H., & Gach, H. M. (2008) · Stroke · doi:10.1161/strokeaha.107.495457 · Cited by 154
Morphologic diagnosis of “vascular dementia” — A critical update
Jellinger, K. A. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.03.006 · Cited by 150
Cognitive reserve and Alzheimer's disease biomarkers are independent determinants of cognition
Vemuri, P., Weigand, S. D., Przybelski, S. A., Knopman, D. S., Smith, G. E., Trojanowski, J. Q., Shaw, L. M. J., DeCarli, C. S., Carmichael, O. T., Bernstein, M. A., et al. (2011) · Brain · doi:10.1093/brain/awr049 · Cited by 164
Cerebral Microinfarcts Associated with Severe Cerebral β‐Amyloid Angiopathy
Soontornniyomkij, V., Lynch, M. D., Mermash, S., Pomakian, J., Badkoobehi, H., Clare, R., & Vinters, H. V. (2009) · Brain Pathology · doi:10.1111/j.1750-3639.2009.00322.x · Cited by 156
Green, M. S., Kaye, J. A., & Ball, M. J. (2000) · Neurology · doi:10.1212/wnl.54.1.105 · Cited by 152
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade
Honjo, K., Black, S. E., & Verhoeff, N. P. L. G. (2012) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100015547 · Cited by 152
The Secondary Prevention of Small Subcortical Strokes (SPS3) Study
Benavente, O., White, C. L., Pearce, L. A., Pérgola, P. E., Roldan, A., Benavente, M.-F., Coffey, C. S., McClure, L. A., Szychowski, J. M., CONWIT, R. A., et al. (2011) · International Journal of Stroke · doi:10.1111/j.1747-4949.2010.00573.x · Cited by 153
Metadata
- Authors
- Snowdon, D. A.
- Corresponding author
- Snowdon, David A.
- ORCID
- Snowdon, David A.
- Venue
- JAMA: The Journal of the American Medical Association
- Publisher
- American Medical Association (AMA)
- Published
- 1997-03-12
- Volume
- 277
- Issue
- 10
- Pages
- 813
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W4296588155
- Cited by
- 1,590
- References
- 0
- Citations by year
- 2026: 23 · 2025: 31 · 2024: 30 · 2023: 39 · 2022: 43 · 2021: 42 · 2020: 51 · 2019: 57 · 2018: 52 · 2017: 60 · 2016: 74 · 2015: 63 · 2014: 71 · 2013: 61 · 2012: 74
- FWCI
- 34.58
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- Funders
- National Institute on Aging (R01AG009862, P50AG005144, KO4AG00553)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neurological Disease Mechanisms and Treatments
- Keywords
- Alzheimer's disease, cerebral infarction, lacunar infarction, dementia, cognitive function, amyloid plaques, neurofibrillary tangles, cerebrovascular disease, atherosclerosis, circle of Willis, thalamic infarction, basal ganglia infarcts, older women, neuropathology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
